←Back to list

Lyra Health

AI-powered global mental health benefits for enterprise employers
Lyra Health provides AI-powered mental health benefits to enterprise employers, combining evidence-based therapy, medication management, and coaching across a network of curated providers. Founded in 2015 by David Ebersman (former Facebook CFO) and Dena Bravata, the company became a unicorn in 2020 and reached a $5.58B valuation in early 2022 following a $235M Dragoneer-led round. Lyra has since raised an additional $200M led by Coatue, bringing total funding to $915M. The platform supports 17M+ employees across 2,500+ organizations including Amgen, eBay, Meta, Morgan Stanley, Starbucks, Uber, and Zoom.
Healthcare 📍 Burlingame, CA Founded 2015
Current Valuation
$5.6B
as of 2022-Q1
UNICORN

QL Price

$5.9B
0% vs last round
QuantLogix's current estimate for Lyra Health, published 2026-10-13 — in line with the last disclosed round of $5.9B (2024-07).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round $5.9B 2024-07 weight 0.21
How this price has held up
No round has priced for Lyra Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-13 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Lyra Health →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Lyra Health, 2026-10-13 (398ea7be4995e714). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Lyra Health going public?
No. Lyra Health is private and has not filed to go public. There is no S-1 on file.
What is Lyra Health's valuation in 2026?
Lyra Health is valued at $5.6B as of 2022-Q1, set by its Funding round ($200M, Jan 2024). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Lyra Health filed an S-1?
No public S-1 is on file for Lyra Health.
Who are Lyra Health's investors?
Lyra Health's investors include Coatue, Dragoneer, Addition, Greylock, IVP, Salesforce Ventures and 1 more.
How much has Lyra Health raised?
Lyra Health has raised $915M in total, most recently a Funding round of $200M in Jan 2024.
Is Lyra Health publicly traded — can you buy Lyra Health stock?
No. Lyra Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Lyra Health on its Pre-IPO Access Desk.
How to actually get exposure to Lyra Health →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

CEO
David Ebersman
Founded
2015
HQ
Burlingame, CA
Employees
~2700
Total Raised
$915M
Growth
17M+ covered lives across 2,500+ employers; global expansion
Last Round
Funding round — $200M (Jan 2024) · Lead: Coatue
IPO Status
private

Fundraising Status

Funding round · $200M · 2y 9mo ago
privateTotal raised $915M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Funding round$200MJan 2024Coatue—

Talent Signal

Hiring trend
▶ Hiring steady
+4% vs 2026-08
Open roles
554
via lever
Product-build share
45%
engineering, research, product, design
Trajectory
steady
product-led hiring — 45% of open roles build product; the rest are go-to-market and G&A.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month534Aug '26554Sep '26
Open roles by function
Open roles by functionOther278Clinical & Science229Sales & GTM14Engineering10Data & ML5Ops & People5Product4Finance & Strategy3Support2
■ product-building   ■ go-to-market / G&A
Analytics EngineerClinical Care Navigator - After HoursClinical Care Navigator - After Hours - Bilingual Spanish SpeakingClinical Product Manager (PhD/PsyD)Clinical Product Specialist, AI DevelopmentEAP Clinical Consultant
Counted from Lyra Health's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

David EbersmanDena Bravata

Investors

Coatue · Dragoneer · Addition · Greylock · IVP · Salesforce Ventures · Sands Capital

Products

  • Lyra Direct Therapy
  • Lyra Care (medication + therapy)
  • Lyra Coaching
  • Lyra Global (international mental health benefits)

Competitors

Spring Health · Modern Health · Headspace Health · Calm Health
HealthcareMental HealthEnterprise Benefits
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.